T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis

被引:432
作者
Axtell, Robert C. [1 ]
de Jong, Brigit A. [1 ,2 ,3 ]
Boniface, Katia [4 ,5 ]
van der Voort, Laura F. [3 ]
Bhat, Roopa [1 ]
De Sarno, Patrizia [6 ]
Naves, Rodrigo [7 ]
Han, May [1 ]
Zhong, Franklin [1 ]
Castellanos, Jim G. [1 ]
Mair, Robert [1 ]
Christakos, Athena [1 ]
Kolkowitz, Ilan [1 ]
Katz, Liat [1 ]
Killestein, Joep [3 ]
Polman, Chris H. [3 ]
Malefyt, Rene de Waal [4 ,5 ]
Steinman, Lawrence [1 ]
Raman, Chander [7 ]
机构
[1] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA
[2] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands
[4] Schering Plough Biopharma, Palo Alto, CA USA
[5] DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA
[6] Univ Alabama, Dept Psychiat & Behav Neurobiol, Birmingham, CA USA
[7] Univ Alabama, Dept Med, Birmingham, CA USA
基金
美国国家卫生研究院;
关键词
AUTOIMMUNE INFLAMMATION; NEUROMYELITIS-OPTICA; IFN-ALPHA; TGF-BETA; GAMMA; DIFFERENTIATION; THERAPY; IL-23; INHIBITION; ACTIVATION;
D O I
10.1038/nm.2110
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferon-beta (IFN-beta) is the major treatment for multiple sclerosis. However, this treatment is not always effective. Here we have found congruence in outcome between responses to IFN-beta in experimental autoimmune encephalomyelitis (EAE) and relapsing-remitting multiple sclerosis (RRMS). IFN-beta was effective in reducing EAE symptoms induced by T helper type 1 (T(H)1) cells but exacerbated disease induced by T(H)17 cells. Effective treatment in T(H)1-induced EAE correlated with increased interleukin-10 (IL-10) production by splenocytes. In T(H)17-induced disease, the amount of IL-10 was unaltered by treatment, although, unexpectedly, IFN-beta treatment still reduced IL-17 production without benefit. Both inhibition of IL-17 and induction of IL-10 depended on IFN-gamma. In the absence of IFN-gamma signaling, IFN-beta therapy was ineffective in EAE. In RRMS patients, IFN-beta nonresponders had higher IL-17F concentrations in serum compared to responders. Nonresponders had worse disease with more steroid usage and more relapses than did responders. Hence, IFN-beta is proinflammatory in T(H)17-induced EAE. Moreover, a high IL-17F concentration in the serum of people with RRMS is associated with nonresponsiveness to therapy with IFN-beta.
引用
收藏
页码:406 / U21
页数:8
相关论文
共 36 条
[1]  
Arnason BGW, 1999, ANNU REV MED, V50, P291
[2]   A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells [J].
Awasthi, Amit ;
Carrier, Yijun ;
Peron, Jean P. S. ;
Bettelli, Estelle ;
Kamanaka, Masahito ;
Flavell, Richard A. ;
Kuchroo, Vijay K. ;
Oukka, Mohamed ;
Weiner, Howard L. .
NATURE IMMUNOLOGY, 2007, 8 (12) :1380-1389
[3]   The interleukin-10 levels as a potential indicator of positive response to interferon beta treatment of multiple sclerosis patients [J].
Bartosik-Psujek, Halina ;
Stelmasiak, Zbigniew .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (07) :644-647
[4]  
Benveniste Etty N, 2007, Sci STKE, V2007, ppe70, DOI 10.1126/stke.4162007pe70
[5]   Distinct characteristics of murine STAT4 activation in response to IL-12 and IFN-α [J].
Berenson, Lisa S. ;
Gavrieli, Maya ;
Farrar, J. David ;
Murphy, Theresa L. ;
Murphy, Kenneth M. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (08) :5195-5203
[6]  
Betti M, 2006, ANN ONCOL, V17, P235
[7]   Cluster analysis and display of genome-wide expression patterns [J].
Eisen, MB ;
Spellman, PT ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868
[8]   Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells [J].
Fitzgerald, Denise C. ;
Zhang, Guang-Xian ;
El-Behi, Mohamed ;
Fonseca-Kelly, Zoe ;
Li, Hongmei ;
Yu, Shuo ;
Saris, Christiaan J. M. ;
Gran, Bruno ;
Ciric, Bogoljub ;
Rostami, Abdolmohamad .
NATURE IMMUNOLOGY, 2007, 8 (12) :1372-U6
[9]   Cytokine changes during interferon-beta therapy in multiple sclerosis: Correlations with interferon dose and MRI response [J].
Graber, Jerome J. ;
Ford, David ;
Zhan, Min ;
Francis, Gordon ;
Panitch, Hillel ;
Dhib-Jalbut, Suhayl .
JOURNAL OF NEUROIMMUNOLOGY, 2007, 185 (1-2) :168-174
[10]   The type IIFN induction pathway constrains Th17-mediated autoimmune inflammation in mice [J].
Guo, Beichu ;
Chang, Elmer Y. ;
Cheng, Genhong .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (05) :1680-1690